• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE's AngioViz Approved by FDA

Article

New product uses parametric imaging to give more infomation than DSA alone

GE Healthcare has recieved FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image, helpful during complex interventional radiology procedures.

AngioViz provides a new visualization of the vascular flow seen in  Digital Subtraction Angiography (DSA) imaging utilizing a technique called parametric imaging. AngioViz looks at each pixel in the image series and determines two things-the peak value of opacification caused by the contrast, and the time it takes for that pixel to reach peak opacification. These two parameters can be displayed as separate images or combined into a single color-coded image that represents parameters of vascular flow. This enables doctors to perceive parameters of flow quickly to support decision-making. In addition, AngioViz allows easy comparison of parametric images from different DSA acquisitions, such as pre- and post-treatment images. This can help physicians understand the impact on flow dynamics of various interventional treatments.

AngioViz bold flow visualization has the potential to be applied to a variety of clinical situations
· Help see where a blocked artery diminishes blood flow in the brain or other tissue
· Identify the timing and amount of blood flow in abnormal vessel anatomy
· Observe flow in abnormal tissue before and after treatment to support interventional oncology treatment
· Visualize peripheral artery blood flow before and after balloon angioplasty and stenting


 

 

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.